Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Micromet sells more shares
Bizjournals.com
Saturday, June 20, 2009 - 9:34am
tags:
Micromet
Clinical Data, Inc. Announces Approval of Generic Name Vilazodone, First in a New Class of Experimental Treatments for Depression
Yahoo/BusinessWire
Saturday, June 20, 2009 - 9:32am
tags:
Clinical Data, Vilazodone, depression
GTC Biotherapeutics Receives Notice Related to NASDAQ Minimum Market Value Rule
Yahoo/BusinessWire
Saturday, June 20, 2009 - 9:31am
tags:
GTC Biotherapeutics
A Meaningless FDA Approval ... for Now
Motley Fool
Saturday, June 20, 2009 - 9:29am
tags:
Novartis, CAPS, Ilaris
Drug stocks diverge from broader market
MarketWatch
Saturday, June 20, 2009 - 9:24am
tags:
AEterna Zentaris share offer to net $9.3 million
Yahoo/AP
Saturday, June 20, 2009 - 9:23am
tags:
Aeterna Zentaris
Healthy Biotech and Pharma ETFs
TheStreet.com
Friday, June 19, 2009 - 9:55am
tags:
ETFs, Gilead Sciences, Amgen
Sun Pharma gets U.S. nod for blood pressure drug
Reuters
Friday, June 19, 2009 - 9:54am
tags:
Sun Pharma, high blood pressure, India, Pfizer, generics, Accupril
AEterna Zentaris to Raise US$10 Million from Institutional Investors at US$1.88 Per Share
Marketwatch
Friday, June 19, 2009 - 9:53am
tags:
Aeterna Zentaris
NBIX's Elagolix Moving Forward
Yahoo/Zacks.com
Friday, June 19, 2009 - 9:52am
tags:
Neurocrine, Elagolix, endometriosis
Cephalon says leukemia drug missed goal in trial
Yahoo/AP
Friday, June 19, 2009 - 9:18am
tags:
Cephalon, leukemia, lestaurtinib
Sanofi CEO Bets Outside U.S., Gears Up for Flu Pandemic, and Seeks To Learn From Biotech
Xconomy
Friday, June 19, 2009 - 9:03am
tags:
Sanofi, Chris Viehbacher, vaccines, H1N1, Pharma CEOs
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Seeking Alpha
Friday, June 19, 2009 - 9:01am
tags:
Spectrum Pharmaceuticals, pipelines, Fusilev, Eoquin
Biotech Stock Mailbag: Gleaming the Cubist
TheStreet.com
Friday, June 19, 2009 - 8:59am
tags:
Cubist Pharmaceuticals, Teva Pharmaceuticals, Arena Pharmaceuticals, Cell Therapeutics
The FDA O.K.'s Novartis' Ilaris
Businessweek
Friday, June 19, 2009 - 8:58am
tags:
Novartis, Ilaris, autoimmune disease, FDA
Hold SGP Until the Acquisition
Yahoo/Zacks.com
Friday, June 19, 2009 - 8:37am
tags:
Schering Plough, buyouts, Merck
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Yahoo
Friday, June 19, 2009 - 8:34am
tags:
FDA, Medicines Company, Angiomax, anticoagulants
AstraZeneca Can’t Stop Testimony by Seroquel Expert Witness
Bloomberg
Friday, June 19, 2009 - 8:33am
tags:
AstraZeneca, Seroquel, lawsuits
Glaxo’s Migraine Pill Spurned by UnitedHealth for Generic Combo
Bloomberg
Friday, June 19, 2009 - 8:32am
tags:
Treximet, migraines, GSK, generics
Hospira wins decision in Sanofi lawsuit
Marketwatch
Friday, June 19, 2009 - 8:31am
tags:
Sanofi, Hospira, Eloxatin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.